Transcatheter Strategy for Severe Mitral Regurgitation Requiring Percutaneous Ventricular Assist Device Support
Authors:
- Tsuyoshi IsawaTsuyoshi Isawa
- on behalf of the J-PVAD InvestigatorsOIon behalf of the J-PVAD Investigators
Open Access
- 10 September 2026
- journal article
- Published by Japanese Circulation Society in Circulation Reports
- Vol. 8 (9) , 1570-1572
Abstract
Background: Data on transcatheter strategies in patients with severe mitral regurgitation (MR) and advanced chronic heart failure requiring Impella support remain limited.Methods and Results: We retrospectively analyzed 33 patients with severe MR and advanced chronic heart failure requiring Impella support, treated with a transcatheter strategy (n=17) or a conservative strategy (n=16). In an overlapweighted Cox model, the transcatheter strategy was associated with a lower in-hospital mortality rate (hazard ratio, 0.13; 95% confidence interval, 0.03–0.52; P=0.004).Conclusions: A transcatheter strategy had survival benefit for this high-risk population.Keywords
This publication has 4 references indexed in Scilit:
- Mitral Transcatheter Edge-to-Edge Repair and Mandatory Mechanical Circulatory Support in Patients With Structural ShockJournal of the Society for Cardiovascular Angiography & Interventions, 2025
- Left Impella®-device as bridge from cardiogenic shock with acute, severe mitral regurgitation to MitraClip®-procedure: a new option for critically ill patientsEuropean Heart Journal: Acute Cardiovascular Care, 2020
- Transcatheter Mitral-Valve Repair in Patients with Heart FailureNew England Journal of Medicine, 2018
- Percutaneous Repair or Surgery for Mitral RegurgitationNew England Journal of Medicine, 2011